National Bowel Cancer Audit – State of the Nation Report 2024 Two-Part Webinar Series

Register below to join an Exclusive Two-Part Webinar Series

We are delighted to invite you to a two-part webinar series presenting insights from the latest National Bowel Cancer Audit (NBOCA) State of the Nation Report (publication due Thursday 9 January 2025). This event will explore critical findings, trends, and actions shaping the future of bowel cancer care in England and Wales. We will have a panel discussion from multidisciplinary healthcare professionals and patient representatives. There will be opportunity for discussion and reflection on the publication’s findings, and we encourage healthy debate from all participants to foster a rich exchange of ideas.

 

Webinar Part I:

  • Date: Tuesday 14 January 2025
  • Time: 17:30 – 18:30
  • Topic: Discussion of the findings and recommendations from the State of the Nation report and the opportunity to ask questions to expert panel.
  • Led by Dr Mike Braun (Clinical Lead for Oncology, NBOCA) and Ms Nicola Fearnhead (Clinical Lead for Surgery, NBOCA).  Chaired by Mr Justin Davies (President, ACPGBI).
  • Panel members to include NBOCA Methodology & Analytical Leads, Nursing and Patient Representatives.

** REGISTER HERE FOR PART I **

 

Webinar Part II:

  • Date: Tuesday 21 January 2025
  • Time: 17:30 – 18:30
  • Topic: Focus on key recommendation(s) from the State of the Nation report and the opportunity to ask questions to expert panel.
  • Led by Dr Mike Braun (Clinical Lead for Oncology, NBOCA) and Ms Nicola Fearnhead (Clinical Lead for Surgery, NBOCA).  Chaired by Mr Martyn Evans (Chairperson, NBOCA Clinical Advisory Group).
  • Panel members to include NBOCA Methodology & Analytical Leads, Nursing and Patient Representatives.

** REGISTER HERE FOR PART II **

 

We look forward to seeing you!

The paper can be accessed here.

The paper can be accessed here.

This work explores the differences in outcomes between patients with and without inflammatory bowel disease that are diagnosed with colorectal cancer.

The paper can be accessed here.